蓝田县高考复读排名濮阳中考复读实力提分快,漯河封闭冲刺靠谱的多少钱,长安区高考补习哪里有升学率,青岛补习实力价格,渭城区全日制冲刺靠谱的排名,雁塔区全日制学校哪里有排名,陕西中考升学率怎么样

A rare albino deer was caught on video at a park in Oakland County, Michigan over the weekend.The video, posted by Mick McDonald, shows the albino deer in Kensington Metropark in Milford.A photo posted to the Pure Michigan Instagram page in early December also shows an albino deer in Kensington park. According to the post, research shows that your chances of seeing an albino in the wild are about 1 in 30,000.  426

A relatively new term we're hearing to help stop the spread of coronavirus is “support bubble.”It’s essentially described as a safer way to socialize and support each other. It’s when family members in different houses or close friends agree to socialize in person, but only with each other to limit the risk of infection.“So, when you join a bubble, you're taking on additional risk and the amount of risk you're taking on is that difference between you and the person with the highest risk in the group,” said Cyrus Shahpar, an epidemiologist with Resolve to Save Lives. “So, it’s important to be vigilant and trust those in the bubble.”Part of a support bubble agreement is that everyone practices the same things outside the bubble, including not forming other bubbles. You should also agree to how long the bubble will last. Obviously, the less people, the lower the risk.It’s also a good strategy for families that need help with things like childcare or taking care of an aging relative.Even professional sports teams and other businesses are somewhat following this theory, setting up things like safe hotels and doing things like testing anyone that comes in.“Then, you tell them they can’t leave the place and inside have to be careful about interaction, then you could theoretically say that’s a safer place than outside the hotel,” said Shahpar.Support bubbles could also help limit virus spread even if someone inside the group were to get the virus, because you already know who the close contacts are.“As we navigate through uncharted waters, we don’t know what’s going to happen. We don’t know how long it’s going to last. So, if this helps us maintain our sanity throughout this pandemic, I think it’s a good idea,” said Shahpar.Other countries and some U.S. counties using the support bubble model are seeing success in lowering cases. 1861

A specific lot of Children’s Advil Suspension in bubble gum flavor is being voluntarily recalled by Pfizer Consumer Healthcare due to overdose concerns.According to a press release from Pfizer, certain four-ounce bottles of the medication contain mislabeled dosage cups. The cups provided are marked in teaspoons and the dosage instructions on the label are described in milliliters. One teaspoon is equal to roughly 4.9 milliliters. "Pfizer performed a Health Hazard Assessment which concluded that the use of the impacted product has a chance of being associated with the potential overdose," the press release says. 661

A significant drop in the number of plastic bags littering Britain's seabeds suggests that a charge on plastic bags and other efforts to tackle marine litter are working, according to a new report.The study, published in the journal Science of the Total Environment, was carried out by scientists at the UK government's Centre for Environment, Fisheries and Aquaculture Science (Cefas), who analyzed data complied between 1992 and 2017 to reveal a drop of nearly 30% in plastic bags on Britain's seabeds.The report inspected 2,461 trawls off the UK's coasts and found that over the 25-year period, 63% of trawls contained at least one plastic litter item. 663

A third leading candidate COVID-19 vaccine has entered a final stage of human testing in the United States. AstraZeneca announced Monday its potential COVID-19 vaccine has entered final trials in the U.S. to test the effectiveness and safety of the product. The Cambridge, England-based company said the trial will involve up to 30,000 adults from various racial, ethnic and geographic groups. The potential vaccine was invented by the University of Oxford and an associated company, Vaccitech.AstraZeneca said development of the vaccine known as AZD1222 is moving ahead globally with late-stage trials in the U.K., Brazil and South Africa. Further trials are planned in Japan and Russia.“To have just one vaccine enter the final stage of trials eight months after discovering a virus would be a remarkable achievement; to have three at that point with more on the way is extraordinary,” Health and Human Services Secretary Alex Azar said in a statement.Two other vaccine candidates began final testing this summer in tens of thousands of people in the U.S. One was created by the National Institutes of Health and manufactured by Moderna Inc., and the other developed by Pfizer Inc. and Germany’s BioNTech. 1215